Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies

SIMPLE SUMMARY: Ovarian cancer is often diagnosed only in advanced stages, which limits therapeutic options and prognosis. Therefore, better and easily accessible methods for the early diagnosis of ovarian cancer are needed. In particular, blood-based biomarkers seem to be promising candidates for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Lars, Rupp, Alexander B. A., Gihr, Kathrin M. E., Kobilay, Makbule, Domroese, Christian M., Mallmann, Michael R., Holdenrieder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605106/
https://www.ncbi.nlm.nih.gov/pubmed/37894448
http://dx.doi.org/10.3390/cancers15205081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605106/
https://www.ncbi.nlm.nih.gov/pubmed/37894448
http://dx.doi.org/10.3390/cancers15205081

Ejemplares similares